MBX Biosciences, Inc. Common Stock enterprise value

The Enterprise Value as of November 2026 (TTM) for MBX Biosciences, Inc. Common Stock (MBX) is 2.57B

According to MBX Biosciences, Inc. Common Stock’s latest financial reports and current stock price. The company's current Enterprise Value is 2.57B. This represents a change of 90.86% compared to the average of 1.35B of the last 4 quarters.

MBX Biosciences, Inc. Common Stock (MBX) Historical Enterprise Value (quarterly & annually)

How has MBX Enterprise Value performed in the past?

The mean historical Enterprise Value of MBX Biosciences, Inc. Common Stock over the last ten years is 773.92M. The current 2.57B Enterprise Value has changed 231.71% with respect to the historical average. Over the past ten years (40 quarters), MBX's Enterprise Value was at its highest in in the June 2026 quarter at 2.58B. The Enterprise Value was at its lowest in in the June 2023 quarter at 0.

MBX Biosciences, Inc. Common Stock (MBX) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of MBX Biosciences, Inc. Common Stock Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

MBX Biosciences, Inc. Common Stock (MBX) Average Enterprise Value

How has MBX Enterprise Value performed in the past?

The current Enterprise Value of MBX Biosciences, Inc. Common Stock (MBX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

MBX Biosciences, Inc. Common Stock (MBX) Enterprise Value vs. Peers

How is MBX’s Enterprise Value compared to its peers?

MBX Biosciences, Inc. Common Stock’s Enterprise Value is less than Viking Therapeutics, Inc. (3.00B), greater than Altimmune, Inc. (364.69M), greater than Skye Bioscience, Inc. (-1966745.00), greater than Biomea Fusion, Inc. (12.33M), less than Rhythm Pharmaceuticals, Inc. (6.40B), greater than Kailera Therapeutics, Inc. (1.46B), greater than Oramed Pharmaceuticals Inc. (153.96M), greater than Lipocine Inc. (6.93M), greater than Xeris Biopharma Holdings, Inc. (2.03B), less than Ascendis Pharma A/S (14.28B),

Build a custom stock screener for MBX Biosciences, Inc. Common Stock (MBX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like MBX Biosciences, Inc. Common Stock using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

MBX Biosciences, Inc. Common Stock (MBX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like MBX Biosciences, Inc. Common Stock or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.